New Delhi, April 7 Aurobindo Pharma announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, which are used to control blood sugar levels in people with type 2 diabetes.The final approval granted by the US Food &...
New Delhi, March 12 Aurobindo Pharma announced on Thursday that it has received an inspection report from the US health regulator, classifying its wholly-owned subsidiary's manufacturing unit in Andhra Pradesh as having a "Voluntary Action Indicated" (VAI) classification, which indicates...
New Delhi, February 22 Aurobindo Pharma aims to increase its production of Penicillin-G to over 10,000 metric tonnes annually over the next 12 months, according to company CFO S Subramanian.The Hyderabad-based drug manufacturer also expects its manufacturing plant in China to achieve EBITDA...